HEALTHeUNIVERSE, Inc.
Not enough financial coverage to compute a composite score for HLUN. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.healtheuniverse.com
Healtheuniverse, Inc. , a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. The company develops stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care.
- CEO
- Vipul Dev
- IPO
- 2013
- HQ
- Covina, CA, US
Price Chart
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 6.45
- Avg Volume
- 18.37K
Get TickerSpark's AI analysis on HLUN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HLUN Coverage
We haven't published any research on HLUN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HLUN Report →